CEBPZ and acute myeloid leukemia: The study presented here used global analyses to investigate differences and similarities between two types of CBF AML: the t(8;21) expressing RUNX1-ETO and the t(3;21) expressing RUNX1-EVI1, which both carry the same RUNX1 DNA-binding domain.